Overview
Portfolio
More
Accelerator Venture Partners
Philadelphia, United States
Accelerator Venture Partners runs a series of FastTrak funds that invest in early‑stage companies, typically between $100k and $1M per company. The firm focuses on high‑growth sectors such as software, fintech, and block...
Portfolio
17+
Employees
5+
Founded
2010
AUM
≈ $4.7M
Investment focus
Stages
Pre-Seed → Series A
Industries
Software OnlyBlockchain & CryptocurrencyFinancial Technology
Geographic scope
United States
Fund details
Funds
AVP 2020 FastTrak Fund LP
Vintage 2020 • $1.0M
AVP 2021 FastTrak Fund LP
Vintage 2021 • $1.2M
AVP 2022 FastTrak Fund
Vintage 2022 • $2.5M
Check sizes
Min: $100.0K
Typical: $100.0K
Max: $1.0M
Sources
Accelerator Venture Partners
Accelerator Venture Partners runs a series of FastTrak funds that invest in early‑stage companies, typically between $100k and $1M per company. The firm focuses on high‑growth sectors such as software, fintech, and blockchain, leveraging the deal flow from the Keiretsu Forum network. By providing a structured fund vehicle, AVP enables accredited investors to participate in diversified early‑stage investments.
Portfolio
17+
Employees
5+
Founded
2010
AUM
≈ $4.7M
Funds
AVP 2020 FastTrak Fund LP · Vintage 2020 • $1.0M
AVP 2021 FastTrak Fund LP · Vintage 2021 • $1.2M
AVP 2022 FastTrak Fund · Vintage 2022 • $2.5M
Check Sizes
Min: $100.0K
Typical: $100.0K
Max: $1.0M
Stages
Pre-Seed → Series A
Industries
Software OnlyBlockchain & CryptocurrencyFinancial Technology
Geographic scope
United States
Sources
Showing 13 of 13 matched portfolio companies
CleanFiber manufactures spray‑in cellulose insulation from recycled corrugated cardboard using a patented wet‑separation process that removes dust and contaminants. The fibers are infused with an all‑borate liquid fire retardant, delivering uniform fire resistance, low‑dust application, and high coverage while meeting ASTM‑C739 standards. The product offers contractors a clean, high‑performance, and price‑stable alternative to traditional newsprint‑based insulation.
Funding: $34.0M
Rough estimate of the amount of funding raised
Funding: $34.0M
Rough estimate of the amount of funding raised
The startup offers a cloud-based management platform that connects industrial machinery to the Internet of Things, enabling real-time data analysis for predictive maintenance and just-in-time parts supply. This technology helps machine operators and manufacturers minimize downtime and enhance productivity through informed decision-making.
Funding: $19.1M
Rough estimate of the amount of funding raised
Funding: $19.1M
Rough estimate of the amount of funding raised
Epilogue Opus is an Enterprise Digital Adoption Platform that enables organizations to create in-application guidance and training resources for enterprise applications, streamlining user onboarding and support. By automating the generation of user assistance content and compliance documentation, it reduces training time and support tickets, enhancing user proficiency and satisfaction.
iQure Pharma develops therapeutics targeting neurodegenerative diseases, utilizing preclinical compounds iQ-007 and iQ-008 that have shown promising results in zebrafish models. The company aims to address the lack of effective treatments for these conditions by advancing iQ-007 into Phase 1 clinical trials in early 2025.
Funding: $8.6M
Rough estimate of the amount of funding raised
Funding: $8.6M
Rough estimate of the amount of funding raised
KEY operates a three-sided marketplace that connects travelers with vetted vacation rental properties and local service providers. This platform addresses the challenge of coordinating luxury accommodations and personalized experiences, allowing users to book homes while accessing tailored in-home services and local activities to enhance their stay.
Maxterial provides a proprietary coating platform that delivers combined wear, heat, and corrosion protection for industrial components. Using advanced chemical formulations, the coatings can be applied with standard spray, dip, or brush methods to metals, alloys, and composites, extending part life and reducing maintenance costs for heavy‑industry manufacturers.
Funding: $8.0M
Rough estimate of the amount of funding raised
Funding: $8.0M
Rough estimate of the amount of funding raised
MaxWell Biosciences develops a synthetic immune system using its CLAROMER® platform, which creates small molecule compounds that mimic innate immune peptides to target a broad spectrum of pathogens. The technology addresses the decline of immune function associated with aging and aims to provide effective treatments for currently untreatable infectious diseases.
Funding: $15.6M
Rough estimate of the amount of funding raised
Funding: $15.6M
Rough estimate of the amount of funding raised
The startup develops biological therapeutics utilizing Chemokine Analogue inhibitors and G-Protein Coupled Receptor modulation to create treatments for serious global health issues. Their focus on enhancing binding affinity and pharmacological control addresses the significant unmet medical needs in therapeutic efficacy.
Funding: $44.7M
Rough estimate of the amount of funding raised
Funding: $44.7M
Rough estimate of the amount of funding raised
OtoNexus Medical Technologies has developed a patented ultrasound otoscope that utilizes through-air ultrasound technology to accurately diagnose middle ear infections in children and adults, distinguishing between viral and bacterial infections. This device enables clinicians to make informed decisions about antibiotic prescriptions, thereby reducing unnecessary usage and improving patient care efficiency.
The startup develops targeted biologics that utilize oncolytic immunotherapy to enhance the efficacy of immune checkpoint inhibitors and cancer vaccines for solid tumors. This approach aims to overcome immune tolerance, providing patients with more effective treatment options for various cancer types.
10+
300+Approximate amount of employees
Funding: $20.9M
Rough estimate of the amount of funding raised
Funding: $20.9M
Rough estimate of the amount of funding raised
Soteria provides patented battery safety technologies, including reinforced separators and current collectors, to mitigate thermal runaway risks in lithium-ion cells. The company facilitates access to these safety innovations through a global consortium and IP exchange under a single license. This system-level approach enables manufacturers across automotive, energy storage, and electronics sectors to design inherently safer battery systems.
Funding: $18.2M
Rough estimate of the amount of funding raised
Funding: $18.2M
Rough estimate of the amount of funding raised
SWIR Vision Systems develops high-resolution CQD® SWIR cameras that provide superior imaging capabilities across various applications, including industrial, automotive, and defense sectors. Their technology overcomes the limitations of traditional InGaAs sensors by offering scalable production and enhanced performance, enabling users to capture detailed images in challenging environments.
Vartega manufactures low-cost recycled carbon fiber (rCF) from post-industrial dry fiber and prepreg scraps, providing a sustainable alternative to virgin carbon fiber for thermoplastic compounding and thermoset applications. By utilizing 96-99% less energy in production, Vartega's rCF maintains comparable mechanical properties while offering custom sizing solutions for enhanced compatibility with various polymers.
Funding: $10.0M
Rough estimate of the amount of funding raised
Funding: $10.0M
Rough estimate of the amount of funding raised
Showing 4 of 4 unmatched portfolio companies